At a glance
- Originator Aventis
- Class Antiprotozoals; Antivirals; Organophosphorus compounds; Purines
- Mechanism of Action Immunosuppressants; Purine-nucleoside phosphorylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; HIV infections; Immunological disorders; Protozoan infections
Most Recent Events
- 03 Aug 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 03 Aug 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 03 Aug 1998 No-Development-Reported for Immunological disorders in USA (Unknown route)